Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to document the extent to which intermittent hypoxia
persists beyond the age of discontinuing clinical methylxanthine, and will assess the effect
of caffeine treatment on the number of intermittent hypoxia episodes and the total number of
seconds with a hemoglobin oxygen saturation (HbO2 SAT) below 90%.